Cancer Discovery
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 29.5 | Q1 | 97.3% | 7.389 | Q1 | 99.5% |
| 2024 | 33.3 | Q1 | 97.2% | 7.283 | Q1 | 99.5% |
| 2023 | 29.7 | Q1 | 97.2% | 7.533 | Q1 | 99.5% |
| 2022 | 28.2 | Q1 | 95.9% | 7.268 | Q1 | 99.6% |
| 2021 | 38.3 | Q1 | 96.6% | 6.084 | Q1 | 99.4% |
| 2020 | — | — | 6.795 | Q1 | 99.4% | |
| 2019 | — | — | 7.513 | Q1 | 99.5% | |
| 2018 | — | — | 7.751 | Q1 | 99.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2159-8290
ISSN
2159-8274
country
UScoverage
2011-2026